Filter
168
Filtered Results: 168
Text search:
enzyme
immunoassays
Featured
Recommendations
29
New Publications
48
Language
Document type
No document type
94
Guidelines
42
Studies & Reports
15
Manuals
7
Fact sheets
5
Strategic & Response Plan
3
Training Material
2
Countries / Regions
India
12
South Africa
4
Colombia
3
Philippines
3
Global
3
Latin America and the Carribbean
3
Germany
3
Bangladesh
3
Indonesia
3
Nepal
2
Ghana
2
Sierra Leone
2
Rwanda
2
Peru
2
Malawi
2
Africa
2
Western and Central Europe
2
Brazil
2
Zambia
2
North Macedonia
1
Kenya
1
Lesotho
1
Cameroon
1
Nigeria
1
Mozambique
1
USA
1
Venezuela
1
Tanzania
1
North America
1
Southern Africa
1
Bolivia
1
Uganda
1
Namibia
1
Ethiopia
1
Angola
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
49
Clinical Guidelines
37
Pharmacy & Technologies
11
Public Health
6
Key Resources
3
Toolboxes
HIV
41
COVID-19
19
Rapid Response
18
TB
5
NTDs
5
Refugee
4
Pharmacy
4
AMR
4
Ebola
3
Zika
3
Natural Hazards
1
Planetary Health
1
NCDs
1
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
New edition
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Volume 1 covers emergency triage assessment and treatment, and acute care for a severely ill or acutely injured patient for approximately the first 24 hours of care. It describes the clinical procedures commonly used in emergency and acute care, and gives a summary of the medicines used and the step...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
J. European Academy of Dermatology and Venereology, 4 August 2014
